John L. Higgins, Chief Executive Officer at LIGAND PHARMACEUTICALS INC (LGND), bought 2,500 shares at $113.50 ($284K) on 2019-05-14, disclosed to the SEC on 2019-05-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| OABI | BUY | 2025-03-21 | $9K | — | Filing → |
| OABI | BUY | 2025-03-20 | $591K | — | Filing → |
| TECH | SELL | 2024-05-16 | $335K | — | Filing → |